Skip to main content
. 2008 Sep;66(3):352–365. doi: 10.1111/j.1365-2125.2008.03257.x

Table 3.

Model building table for nicorandil pharmacodynamics and disease progress

Model Disease progress Drug effect Random effects Estimation Obj Sig
10 Exponential Emax Covariance of S0, SS, EC50 Simultaneous 7600.48 5.9
11 Exponential Emax Covariance of S0, SS, EC50 Sequential 7601.34 6.5
12 Exponential Linear Covariance of S0, SS, EC50 Sequential 7624.16 5.4
13 Exponential Emax No covariance Sequential 7624.92 5.9
14 Linear Sigmoid Emax Covariance of S0, alpha, Emax, EC50 Sequential 7634.66 6.6
15 Linear Emax Covariance of S0, alpha, Emax, EC50 Sequential 7634.80 6.3
16 Linear Emax No covariance Sequential 7639.33 5.9
17 None Emax Covariance of S0, Emax, EC50 Sequential 7664.96 .

Obj, NONMEM objective function value; Sig, NONMEM estimate of minimum number of significant digits in the parameter estimates.